PDB39 EFFECT OF VARYING MODELLING ASSUMPTIONS ON THE COSTEFFECTIVENESS OF LIRAGLUTIDE 1.2 MG (AS A COMPONENT OF DUAL THERAPY) IN TYPE 2 DIABETES
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72097-6
https://www.valueinhealthjournal.com/article/S1098-3015(11)72097-6/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
256
First Page :
A290
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72097-6&doi=10.1016/S1098-3015(11)72097-6